Clinical Trials Browser

Phase 1/2 × Bulbo-Spinal Atrophy, X-Linked × enzalutamide × Clear all

NCT03437941 2023-05-06

Study to Evaluate CORT125281 in Combination With Enzalutamide in Patients With mCRPC

Phase 1/2 Completed

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked